← Eichor
Study identifier: NCT06183281 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Integrating Nonpharmacologic Strategies for Pain With Inclusion, Respect, and Equity

Condition: Chronic Pain  ·  Sponsor: University of California, San Francisco

PhaseNA
Planned participants586
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

INSPIRE creates a trilingual mobile app and telehealth coaching program to promote non-pharmacologic strategies for pain management with Black, Chinese, and Latinx communities in the San Francisco Bay Area. Years 1-2 will develop the app and test it with a brief single arm pilot starting in Nov 2023. A full two arm randomized controlled trial (RCT) will being in early 2025 with changes in PEG scores as the primary outcome. Secondary outcomes include Helping to End Addiction Longterm (HEAL) common data elements.

This description comes directly from the study's public registry record.

Talk to the study team

Jason Satterfield, PhD  ·  415-353-2104  ·  Jason.Satterfield@ucsf.edu

Always discuss trial participation with your own doctor first.

Locations (2)

San Francisco General HospitalSan Francisco, California, United StatesRecruiting
UCSF Adult Primary Care Mt. Zion ClinicSan Francisco, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06183281